Comparative Pharmacology
Head-to-head clinical analysis: HYDROXOMIN versus RUBRAMIN PC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HYDROXOMIN versus RUBRAMIN PC.
HYDROXOMIN vs RUBRAMIN PC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydroxocobalamin is a synthetic form of vitamin B12 that acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis. It also acts as a direct scavenger of cyanide ions by binding to them to form cyanocobalamin, which is excreted renally.
Cyanocobalamin (vitamin B12) is essential for DNA synthesis, myelin formation, and hematopoiesis. It acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase.
100 mg intramuscularly or deep subcutaneously three times a week.
1000 mcg intramuscularly once daily for 5-7 days, then 1000 mcg intramuscularly once weekly for 4 weeks, followed by 1000 mcg intramuscularly once monthly.
None Documented
None Documented
Terminal elimination half-life approximately 4-6 hours; may extend to 8-12 hours in moderate to severe renal impairment (CrCl <30 mL/min).
Terminal elimination half-life: 6-7 hours in normal renal function; prolonged to 7-10 hours in elderly; significantly extended in renal impairment (up to 80 hours in ESRD), requiring dose adjustment
Primarily renal (80-90% unchanged) with minor biliary/fecal elimination (5-10%); total clearance ~150 mL/min.
Renal: 50-98% as unchanged drug via glomerular filtration and tubular secretion; biliary/fecal: <1%
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement